BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly

  Appointed in August 2016, Richard also served on the Board’s Audit and Compensation Committees.

  November 8, 2017

   · 

  6 min read
• Biotech Beach

  Regen BioPharma’s Chief Scientific Officer Explains the Link Between its NR2F6 Medicinal Chemistry and Three-Dimensional X-Ray Structure Programs

  The company recently began a program to determine the three-dimensional structure of the NR2F6 nuclear receptor.

  November 8, 2017

   · 

  3 min read
• Important Tax Notice to U.S. Shareholders of Portage Biotech

  This statement is provided for shareholders who are United States persons for purposes of the U.S. Internal Revenue Code of 1986, as amended and the related United States Treasury regulations.

  November 8, 2017

   · 

  2 min read
• Business

  Nortech Systems Reports Third Quarter Results

  Nortech Systems today reported net sales of $28.3 million for the third quarter ended September 30, compared with net sales of $29.7 million for the third quarter of 2016.

  November 8, 2017

   · 

  5 min read
• Business

  ViewRay Announces Conference Call and Webcast of Third Quarter 2017 Financial Results to be Held on November 13, 2017

  ViewRay will hold a conference call on Monday, November 13, 2017 at 8:30 a.m. ET / 5:30 a.m. PT to discuss the results.

  November 8, 2017

   · 

  1 min read
• Business

  Novus Therapeutics Reports Third Quarter 2017 Results

  For the third quarter of 2017, Novus reported a net loss of $3.0 million, or $0.43 loss per share, compared to a net loss of $2.0 million, or $4.35 loss per share, for the same period in 2016.

  November 8, 2017

   · 

  16 min read
• 

  FDA

  DT MedTech Wins FDA Nod for Hintermann Series H2 Total Ankle Replacement System

  The Hintermann Series H2 is a semi-constrained, total ankle replacement prosthesis developed by a world-renowned foot and ankle surgeon based in Switzerland.

  November 8, 2017

   · 

  3 min read
• Business

  Alliar Announces 3Q17 Results

  Net revenue1 growth of 14.0% in Q3, with same store sales of 7%. YTD growth of 18.0%, SSS of 11%.

  November 8, 2017

   · 

  1 min read
• FDA

  Orthocell Receives CE Mark for CelGro

  CelGro, for a range of dental bone and soft tissue regeneration procedures, can now be marketed and sold within the European Union (EU).

  November 8, 2017

   · 

  4 min read
• Business

  Sage Therapeutics Appoints Asha Nayak, M.D., Ph.D., to Board of Directors

  Dr. Nayak currently serves as chief medical officer at Intel Corporation where she guides its healthcare investment strategy and provides clinical and business leadership to Intel’s broad spectrum of healthcare programs.

  November 8, 2017

   · 

  2 min read